Corporate News     09-Dec-22
Alembic Pharmaceuticals receives USFDA approval for Desonide Cream
Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA), Desonide Cream, 0.05%. The ANDA was filed by Aleor Dermaceuticals Limited (Aleor) which was amalgamated with Alembic. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Desonide Cream, 0.05%, of Padagis US LLC. Desonide Cream, 0.05% is a Low potency corticosteroid indicated for the relief of inflammatory and Pruritic manifestations of corticosteroid-responsive dermatoses. Refer to our label for full indication.

Desonide Cream, 0.05%, has an estimated market size of US$12 million for twelve months ending Sep 2022 according to IQVIA.

Alembic has received a cumulative total of 178 ANDA approvals (155 final approvals and 23 tentative approvals) from USFDA.

Previous News
  Alembic Pharma’s Gujarat facility gets 4 observations from USFDA
 ( Hot Pursuit - 09-Mar-24   09:04 )
  Alembic Pharmaceuticals update on its Namthang facility in Sikkim
 ( Corporate News - 04-Oct-23   14:52 )
  Alembic Pharma's oncology formulation facility undergoes USFDA audit
 ( Corporate News - 09-Mar-24   12:26 )
  Alembic Pharma gains as Karkhadi facility gets EIR from USFDA
 ( Hot Pursuit - 16-Feb-23   15:42 )
  Alembic Pharmaceuticals consolidated net profit declines 29.03% in the December 2022 quarter
 ( Results - Announcements 01-Feb-23   17:10 )
  Alembic Pharma suspends Sikkim facility operations due to floods
 ( Hot Pursuit - 04-Oct-23   14:39 )
  Volumes soar at Aditya Birla Fashion & Retail Ltd counter
 ( Hot Pursuit - 08-May-23   14:30 )
  Alembic Pharmaceuticals receives USFDA approval for Prazosin Hydrochloride Capsules
 ( Corporate News - 08-Mar-23   09:14 )
  Alembic Pharma gets USFDA final approval for Prazosin Hydrochloride capsules
 ( Hot Pursuit - 08-Mar-23   09:19 )
  Alembic Pharmaceuticals receives EIR for its Injectable Facility at Karkhadi
 ( Corporate News - 16-Feb-23   15:25 )
  Alembic Pharma gets PAS nod from USFDA for pregabalin capsules
 ( Hot Pursuit - 22-Dec-22   14:57 )
Other Stories
  Just Dial to announce Quarterly Result
  10-Jul-24   19:55
  Ashish Polyplast schedules board meeting
  10-Jul-24   19:55
  Umang Dairies AGM scheduled
  10-Jul-24   19:53
  Network 18 Media & Investments to conduct board meeting
  10-Jul-24   19:53
  Hathway Bhawani Cabletel & Datacom to conduct AGM
  10-Jul-24   19:40
  Board of Steel City Securities recommends interim dividend
  10-Jul-24   19:39
  Metal Coatings (India) to hold AGM
  10-Jul-24   19:39
  Delta Corp to hold AGM
  10-Jul-24   19:39
  Hathway Cable & Datacom to conduct AGM
  10-Jul-24   19:39
  GE Power India wins order of Rs 7.66 cr
  10-Jul-24   19:18
Back Top